Research

Treatment of Ultra-Small Proximal Pole Scaphoid Fracture

IRB Number: 11088

Institutional Review Board, Hospital for Special Surgery

July 21, 2011

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Michelle G. Carlson, MD

Co-Investigators

Andrew J. Weiland, MD
Peter Evans, MD
Jeffrey Lawton, MD
Charles Melone, MD
Joseph Schreiber, MD 
Tracy Klein, MSW

Summary

As subject population will be determined via retrospective chart review, we are not actively recruiting subjects. 

Patient charts will be identified through retrospective review of the co-investigators’ files.  The review will include all patients diagnosed with ultra-small proximal pole scaphoid fractures who underwent fixation using a micro screw for small bone fragments, such as the Acutrak 2 Micro.
Post surgical scaphoid union and range of motion will be evaluated.
 

Inclusion/Exclusion Criteria

N/A – we are not actively recruiting subjects

Contact Information

Tracy Klein
kleint@hss.edu
212.774.2727



Request an Appointment